PT
Autoridade da Concorrência

Case details

Print
Merger control
Case reference
CCENT/2006/46 - RECORDATI ESPANHA / JABA FARMACÊUTICA
Acquired
JABA Farmacêutica, S.A.
Description
JABA FARMACÊUTICA - a Portuguese-registered company that is a member of the Jaba Group, whose main economic activity is the production and sale of medicines, including those carrying its own trade name, generics, prescription medicines and OTC medicines.
Acquiring
Recordati España, SL
Description
RECORDATI ESPANHA a Spanish-registered company that is a member of the Recordati Group; it operates in the field of the R&D, production and marketing of pharmaceuticals for human use.
Sector
  • Extractive and manufacturing Industries
Activity (NACE)
  • C21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
Applicable legislation
Art. 9(1)(a) (Law 18)
Notification thresholds
Market share
Type of merger
Conglomerate
Cooperation with sector regulators
Status
Closed
Type of Investigation
Phase 1
AdC’s decision
Case description
Notified on 25 September, this merger consists of the acquisition by RECORDATI ESPAÑA SL ("RECORDATI ESPANHA") of sole control of the companies JABA FARMACÊUTICA SA ("JABA FARMACÊUTICA"), JABAFARMA - PRODUTOS FARMACÊUTICOS SA ("JABAFARMA") and BONAFARMA - PRODUTOS FARMACÊUTICOS SA ("BONAFARMA"), held at present by JABA, SGPS, SA.
Timeline
2006-11-16
COMPETITION AUTHORITY approves the acquisition of sole control of JABA FARMACÊUTICA, JABAFARMA and BONAFARMA by the undertaking RECORDATI ESPANHA
Click here to see your activities